References:
  1. Bakst RL, Campbell BA, Pinnix CC. PET Guided Therapy for Early Stage Hodgkin Lymphoma: Are We Positive About a Negative Interim Scan? Int J Radiat Oncol Biol Phys 2020;107(1):12-17.
  2. Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, et al. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma: a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol 2022;23(1):125.
  3. Arora RS, Bakhshi S. Indian Pediatric Oncology Group (InPOG) – Collaborative research in India comes of age. Pediatr Hematol Oncol 2016;1(1):13–17.
  4. Arora RS, Mahajan A, Dinand V, Kalra M, Jain S, Taluja A, et al. InPOG-HL-15-01 - Challenges and lessons learnt in setting up the first collaborative multicentre prospective clinical trial in childhood cancer in India. Pediatr Hematol Oncol 2020;5(4):166-170.
  5. Mahajan A, Singh M, Bakhshi S, Jain S, Radhakrishnan V, Verma N, et al. Treating early‐stage Hodgkin lymphoma in resource‐limited settings: InPOG‐HL‐15‐01 experience. Pediatr blood cancer 2021;68(10):1-9.
  6. Jain S, Bakhshi S, Seth R, Verma N, Singh M, Mahajan A, et al. Risk based and response adapted radiation therapy for children and adolescents with newly diagnosed advanced stage Hodgkin lymphoma treated with ABVD chemotherapy: a report from the Indian pediatric oncology group study InPOG-HL-15-01. Leuk. Lymphoma ;ahead-of-print(ahead-of-print):1-8.
  7. Lopez-Alonso R, Qi S, Mashiach T, Weiler-Sagie M, Yahalom J, Dann EJ. The presence of a bulky mediastinal mass of 7 cm or greater in diameter confers an adverse prognosis to patients with advanced Hodgkin lymphoma in case of negative interim PET/CT. Leuk. Lymphoma 2021;62(6):1313.
  8. Trotman J, Barrington SF. The role of PET in first-line treatment of Hodgkin lymphoma. Lancet Haematol 2021;8(1):e67-e79.
  9. Panebianco M, Bagni O, Cenfra N, Mecarocci S, Ortu La Barbera E, Filippi L, et al. Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin lymphoma. Leuk Res 2019;76:48-52.
  10. Gómez León N, Delgado-Bolton R, del Campo del Val, Lourdes, Cabezas B, Arranz R, García M, et al. Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi–Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients with Lymphoma. Clin Nucl Med 2017;42(8):595-602.
  11. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, et al. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014;32(27):3048-3058.
  12. Voltin C, Mettler J, Grosse J, Dietlein M, Baues C, Schmitz C, et al. FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated Overview. Cancer 2020;12(3):601.
  13. Parambil BC, Narula G, Prasad M, Shah S, Shet T, Shridhar E, et al. Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk‐adapted approach in a tertiary cancer center in India. Pediatr Blood Cancer 2020;67(2):1-7.
  14. Palayullakandi A, Trehan A, Jain R, Kumar R, Mittal BR, Kapoor R, et al. Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric Hodgkin lymphoma in a LMIC setting. Pediatr Hematol Oncol 2022;10:1-13
  15. Totadri, S., Radhakrishnan, V., Ganesan, T.S., Ganesan, P., Kannan, K., Lakshmipathy, K.M., Selvaluxmy, G., & Sagar, T.G. Can Radiotherapy Be Omitted in Children With Hodgkin Lymphoma Who Achieve Metabolic Remission on Interim Positron Emission Tomography? Experience of a Tertiary Care Cancer Referral Center. J Glob Oncol 2018;4:1-7.
  16. Kelly KM, Cole PD, Pei Q, Bush R, Roberts KB, Hodgson DC, et al. Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group. Br J Haematol 2019;187(1):39-48.
  17. Wolden SL, Lu Chen, Kelly KM, Herzog P, Gilchrist GS, Thomson J, et al. Long-Term Results of CCG 5942: A Randomized Comparison of Chemotherapy With and Without Radiotherapy for Children With Hodgkin Lymphoma—A Report From the Children’s Oncology Group. J Clin Oncol 2012;30(26):3174-3180.
  18. Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. J Glob Oncol 2019;(5):1-13.
  19. Shaikh PM, Alite F, Pugliese N, Picardi M, Vargo JA. Consolidation radiotherapy following positron emission tomography complete response in early-stage Hodgkin lymphoma: a meta-analysis. Leuk. Lymphoma 2020 ;61(7):1610-1617.
  20. Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, et al. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin lymphoma with post-chemotherapy negative positron emission tomography scans. Leuk. Lymphoma 2007;48(9):1721-1727.
  21. Radford J, Illidge T, Counsell N, Hancock B, Pettengell R, Johnson P, et al. Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin Lymphoma. N Engl J Med 2015;372(17):1598-1607.
  22. André M, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, et al. Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial. J Clin Oncol 2017;35(16):1786.
  23. Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, et al. Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group. J Clin Oncol 2019;37(31):2835-2845.
  24. Stephens DM, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, et al. Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. Blood 2019;134(15):1238-1246.
  25. Borchmann P, Plütschow AJ, Kobe C, Greil R, Meissner J, Topp MS, et al. PET-Guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma: a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2021;22(2):223.